Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-22

Clinical Trial Update: Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tamsulosin alone or in combination with solifenacin for men with lower urinary tract symptoms including overactive bladder; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin (solifenacin)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Astellas Pharma Taiwan, Inc. | Conditions: Lower Urinary Tract Symptoms, Overactive Bladder | Phase 4 | Status: COMPLETED